Related Experiment Video
Updated: Aug 10, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Compliance with secondary prevention of ischemic stroke: a prospective evaluation
T Sappok1, A Faulstich, E Stuckert
1Department of Neurology, Stroke Unit, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Germany.
Insights
Patient compliance with secondary stroke prevention medication is good one year after ischemic stroke. Older age, greater stroke severity, and cardioembolic stroke predict better adherence to antithrombotic and risk factor treatments.
Area of Science:
- Neurology
- Cardiology
- Public Health
Background:
- Secondary prevention of ischemic stroke relies on patient adherence to pharmacological therapies.
- Limited data exist on patient compliance outside clinical trials for antithrombotic and risk factor treatments.
- Understanding compliance is crucial for effective stroke prevention strategies.
Purpose of the Study:
- To assess the rate of patient compliance with secondary stroke prevention 1 year after cerebral ischemia.
- To identify predictors of compliance with antithrombotic and risk factor medications.
- To determine reasons for noncompliance in stroke patients.
Main Methods:
- Prospective recruitment of patients with ischemic stroke or TIA on antithrombotic medication.
- Structured telephone interviews at 1 year to evaluate compliance with antithrombotic and risk factor medications.
- Logistic regression analysis to identify independent predictors of compliance.
Main Results:
- At 1 year, 87.6% of patients remained on antithrombotic medication, and 70.2% were on the same agent.
- Compliance rates for hypertension, diabetes, and hyperlipidemia treatment were 90.8%, 84.9%, and 70.2%, respectively.
- Older age, higher stroke severity on admission, and cardioembolic stroke cause were significant predictors of compliance.
Conclusions:
- Compliance with secondary stroke prevention is generally good 1 year post-ischemic stroke in this study cohort.
- Factors associated with better long-term compliance include advanced age, severe neurological deficits, and cardioembolic stroke etiology.
- Identifying compliance determinants can guide interventions to enhance stroke prevention quality.
Background And Purpose:
Compliance with pharmacological therapy is essential for the efficiency of secondary prevention of ischemic stroke. Few data exist regarding patient compliance with antithrombotic and risk factor treatment outside of controlled clinical trials. The aim of the present study was to assess the rate of and predictors for compliance with secondary stroke prevention 1 year after cerebral ischemia and to identify reasons for noncompliance.
Methods:
Patients with a diagnosis of ischemic stroke or TIA and antithrombotic discharge medication were prospectively recruited. At 1 year, the proportion of patients compliant with antithrombotic treatment and with medication for risk factors (eg, hypertension, diabetes, hyperlipidemia) was evaluated through structured telephone interviews. In addition, the reasons for nontreatment with antithrombotic and risk factor medication were determined. Independent predictors for compliance were analyzed by logistic regression analyses.
Results:
Of 588 consecutive patients admitted to our stroke unit, 470 had a discharge diagnosis of cerebral ischemia (TIA 26.2%, cerebral infarct 73.8%) and recommendations for antithrombotic therapy. At 1 year, 63 patients (13.4%) had died and 21 (4.5%) were lost to follow-up, thus, 386 could finally be evaluated. Of the patients, 87.6% were still on antithrombotic medication, and 70.2% were treated with the same agent prescribed on discharge. Of the patients with hypertension, diabetes, and hyperlipidemia, 90.8%, 84.9%, and 70.2% were still treated for their respective risk factors. Logistic regression analyses revealed age (OR 1.03, 95% CI 1.00 to 1.06), stroke severity on admission (OR 1.09, 95% CI 1.00 to 1.20), and cardioembolic cause (OR 4.13, 95% CI 1.23 to 13.83) as independent predictors of compliance.
Conclusions:
Compliance with secondary prevention in patients with ischemic stroke is rather good in the setting of our study. Higher age, a more severe neurological deficit on admission, and cardioembolic stroke cause are associated with better long-term compliance. Knowledge of these determinants may help to further improve the quality of stroke prevention.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Atherosclerosis III: Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Ischemic Stroke l: Introduction
